InvestorsHub Logo
Followers 52
Posts 2230
Boards Moderated 0
Alias Born 07/06/2011

Re: frrol post# 3035

Monday, 11/14/2022 3:35:03 PM

Monday, November 14, 2022 3:35:03 PM

Post# of 3063
Hey frrol! Good luck with AVXL, and NGENF, each with promising neuroprotective drugs, like NR. Such a tricky space (neurodegeneration in general), but with such a great need and potentially huge reward.

Some anti-amyloid antibody trials have failed in Alzheimer's recently, and some have reported more promising results. I think that gene regulation for amyloid and tau knockdown are also very promising avenues to pursue.

I wonder what the recent news of NMN being taken away as a supplement by FDA will do for NR supplement business, or if/when CDXC will be moving on to the second generation NAD+ boosters, which seem much more potent (and hopefully the IP is really locked away!). Still trying to understand the results and implications of all the lawsuits with Elysium on CDXC's NR business, but it seems like those are all winding down and nothing much good came of it all for CDXC.

https://www.naturalproductsinsider.com/regulatory/trade-groups-react-fda-decision-%CE%B2-nmn-supplements
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News